Is there still a role for fine-needle aspiration cytology in breast cancer screening? Experience of the verona mammographic breast cancer screening program with real-time integrated radiopathologic activity (1999-2004)

Cancer

Volumn 114, Issue 2, 2008, Pages 74-82

  Manfrin, Erminia ^a   Mariotto, Renata ^b   Remo, Andrea ^a   Reghellin, Daniela ^a   Dalfior, Daniela ^a   Falsirollo, Francesca ^c   Bonetti, Franco ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

^c Marzana Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; BREAST BIOPSY; BREAST CANCER; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ECHOMAMMOGRAPHY; FEMALE; HEALTH PROGRAM; HUMAN; MAMMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RADIODIAGNOSIS;

ADENOCARCINOMA; AGED; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CYTOLOGICAL TECHNIQUES; FEMALE; HUMANS; ITALY; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 43149113260     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23412     Document Type: Article

References (25)

1. Frost AR, Tabbara SO, Poprocky LA, Weiss H, Sidawy MK. Cytologic features of proliferative breast disease: a study designed to minimize sampling error. Cancer. 2000;90:33-40.
2. Sidawy MK, Tabbara SO, Bryan JA, Poprocky LA, Frost AR. The spectrum of cytologic features in nonproliferative breast lesions. Cancer. 2001;93:140-145.
3. Perry N, Breeders M, de Wolf C, Tornemberg S, Holland R, von Karsa L. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities; 2006.
4. Wells CA, Perera R, White FE, Domizio P. Fine needle aspiration cytology in the UK breast screening programme: a national audit of results. Breast. 1999;8:261-266.
5. Pisano ED, Fajardo LL, Tsimikas J, et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: the Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 investigators. Cancer. 1998;82:679-688.
6. Pisano ED, Fajardo LL, Caudry DJ, et al. Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. Radiology. 2001;219:785-792.
7. Tabbara SO, Frost AR, Stoler MH, Sneige N, Sidaway MK. Changing trends in breast fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Survey. Diagn Cytopathol. 2000;22:126-130.
8. Lieske B, Ravichandran D, Wright D. Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma. Br J Cancer. 2006;95:62-66.
9. Duijm LE, Groenewoud JH, Roumen RM, de Koning HJ, Plaisier ML, Fracheboud J. A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer. Breast Cancer Res Treat. 2007;106:113-119.
10. Dray M, Mayall F, Darlington A. Improved fine needle aspiration (FNA) cytology results with near patient diagnosis service for breast lesions. Cytopathology. 2000;11:32-37.
11. Ljung BM, Drejet A, Chiampi N, et al. Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique. Cancer. 2001;93:263-268.
12. Singh N, Ryan D, Berney D, Calaminici M, Sheaff MT, Wells CA. Inadequate rates are lower when FNAC samples are taken by cytopathologists. Cytopathology. 2003;14:327-331.
13. Levine T. Breast cytology-is there still a role? Cytopathology. 2004;15:293-296.
14. Bulgaresi P, Cariaggi P, Ciatto S, Houssami N. Positive predictive value of breast fine needle aspiration cytology (FNAC) in combination with clinical and imaging findings: a series of 2334 subjects with abnormal cytology. Breast Cancer Res Treat. 2006;97:319-321.
15. Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol. 2002;27:1-4.
16. Dey P, Bundred N, Gibbs A, et al. Costs and benefits of a 1 stop clinic compared with a dedicated breast clinic: randomised controlled trial. BMJ. 2002;324:507.
17. Roche NA, Ray SA, Layer GT. Immediate cytodiagnosis and imaging in the clinical management of discrete benign breast lesions. Ann R Coll Surg Engl. 1997;79:268-271.
18. Houssami N, Irwing L. Likelihood ratios for clinical examination, mammography, ultrasound and fine needle biopsy in women with breast problems. Breast. 1998;7:85-89.
19. Mariotto R, Brancato B, Bonetti F, et al. Real-time reading in mammography breast screening. Radiol Med (Torino). 2007;112:287-303. Epub 2007 Mar 19.
20. Giordano L, Giorni D, Piccini P, et al. Trend temporali di alcuni indicatori dei programmi di screening mammografico in Italia: 1996-2004. Quinto Rapporto. Osservatorio Nazionale Screening. Milano: Ed. Inferenze scarl, 2005:32-46.
21. Zorzi M, Fedato C, Cogo C, Vettorazzi M.I programmi di Screening oncologici del Veneto. Rapporta 2005. Istituto Oncologico Veneto, Registre dei tumori del Veneto. Ed. CLEUP, 2007:45.
22. Ciatto S, Houssami N, Ambrogetti D, Bonardi R, Collini G, Del Turco MR. Minority report - false-negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis. Breast Cancer Res Treat. 2007;105:37-43.
23. Lamb J, Anderson TJ, Dixon MJ, Levack PA. Role of fine needle aspiration cytology in breast cancer screening. J Clin Pathol. 1987;40:705-709.
24. Litherland JC. Should fine needle aspiration cytology in breast assessment be abandoned? Clin Radiol. 2002;57:81-84.
25. Berner A, Davidson B, Sigstad E, Risberg B. Fine-needle aspiration cytology vs. core biopsy in the diagnosis of breast lesions. Diagn Cytopathol. 2003;29:344-348.